Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

NICE backs device to treat complex aneurysms

  • Comment

Final medical technology guidance on how to use a device for treating complex aneurysms and tears in the wall of the thoracic aorta is due to be published.

The NICE guidance supports, in a selected group of patients, the use of the E-vita open plus device, which consists of two sections that are joined together to allow two areas of damaged aorta to be treated in one procedure.

The device allows the blood to flow through the device, instead of into the aneurysm or the tear, and can also replace some of the aorta if it is badly damaged. Eventually the blood in the aneurysm or the damaged aorta wall forms a clot that poses no further risk.

NICE recommends the use of E-vita open plus in patients who might otherwise need two operations because of the extent of disease or damage affecting their aorta.

Using the device will make it less likely that a second procedure has to be carried out, reducing the associated risk of serious complications.

As a result, outcomes for patients are improved, and using the device is also expected to be more cost-effective than standard two-stage procedures.

Professor Carole Longson, director of the NICE Centre for Health Technology Evaluation, said: “This final guidance supports the NHS using the E-vita open plus for treating complex aneurysms (bulging blood vessels) and tears in the wall of the aorta.”

Are you able to Speak Out Safely? Sign our petition to put pressure on your trust to support an open and transparent NHS.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.